Magazine Pharmaceutiques n°328
By Julie Wierzbicki – June-July 2025
From the processing of raw materials to patient administration, targeted radionuclide therapy follows a complex pathway requiring the coordination of many stakeholders. The success of this technology rests on a shared responsibility between industry players and healthcare professionals.
Reference
Source: Magazine Pharmaceutiques, n°328
Author: Julie Wierzbicki
Date: June-July 2025
Link to original article: Magazine Pharmaceutiques n°328